U.S. Food and Drug Administration Approves Cayston(R) (Aztreonam for Inhalation Solution) for the Improvement of Respiratory Symptoms in Cystic Fibrosis Patients with Pseudomonas Aeruginosa)
Link: CF Foundation Plays Important Role in Bringing New Inhaled Antibiotic Cayston to Patients
Tuesday, February 23, 2010
blog comments powered by Disqus
Subscribe to:
Post Comments (Atom)